Immunomedics Inc (NASDAQ:IMMU)

Delayed Data
As of Oct 17
 +0.56 / +3.66%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 26.50, with a high estimate of 40.00 and a low estimate of 16.00. The median estimate represents a +67.09% increase from the last price of 15.86.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 8.44%
Growthannually 9.27%


Growthquarterly --
Growthannually 863.19%
Key to the earnings and sales forecast charts.